Karen Sofía Valenzuela Villela obtained her BS in Biomedical Engineering in 2018 and her master's degree in Materials Sciences in 2020, both from the Universidad Autónoma de Ciudad Juárez. She is currently pursuing a doctorate in Materials Sciences and is involved in teaching within the Biomedical Engineering program. Karen's research is primarily focused on 3D printing, nanotechnology, and microtechnology with applications in health, specifically within the Nanomedicine Research Group at the Universidad Autónoma de Ciudad Juárez. Her notable projects include the development of core-shell nanoparticles composed of magnetite, polyethylene glycol, and polylactic acid, proposed as non-viral vectors for cancer treatment. Additionally, she has worked on polymeric microparticles based on starch and polyethylene glycol for the prolonged release of folic acid in the gastrointestinal tract and on 3D-printed polymeric stents made from polycaprolactone. Her publications include studies on the stability of starch-folic acid/polyethylene glycol particles for gastrointestinal drug delivery, focusing her attention on drug delivery systems and biomedical materials.

Karen Valeria Alvarado Araujo received her B.S. degree in Biomedical Engineering from the Universidad Autonoma de Ciudad Juarez in 2023 and is now working in the private sector. She graduated with the research project Systems for the release of folic acid microparticles coated with starch/PEG in the presence of gastric conditions using pepsin and amylase, working in the research group of NanomedicineUACJ https://sites.google.com/view/nanomedicine/home under the direction of Dr. Christian Chapa, whose research topics mainly include technological developments in health, wound management, control in the release of genes, drugs, active ingredients through micro and nanostructured systems based on polymeric biomaterials in different presentations such as hydrogels, particles, including electrospun ones, and synthesis and characterization of nanoparticles and magnetic semiconductors, based on ferrites, magnetite, magnetic, and ceramics, and respective tests of cytotoxicity, genotoxicity, and hemolysis, among other tests of cellular and animal response.

Dr. Perla García is a Centro de Investigación en Química Aplicada researcher in Saltillo, Coahuila, México. She has significantly contributed to materials and research, publishing 83 indexed articles according to Scopus. Additionally, she holds 4 patents and has written 4 book chapters. Dr. Garcia has led 12 externally funded projects and supervised graduate and undergraduate theses. Among her recognitions are awards for the business incubation process of "Parche transdérmico" granted by Fideicomiso Estatal para el Fomento de las Actividades Productivas en el Estado de Chihuahua FIDEAPECH-UACJ and by Centro de Innovación y Desarrollo Económico Regional (CIDER). She was the founding president of the Asociación Mexicana de Materiales Compuestos and led the Red Temática de Materiales Compuestos from 2016 to 2019. Currently, she is working on a health-related project focused on developing and characterizing polymeric and metallic nanocomposites with biomedical applications. Her goal is to achieve regenerative and antimicrobial properties for chronic wound reconstruction. Other studies include synthesizing gold and magnetite nanoparticles, evaluating their physicochemical and biological properties like cytotoxicity and biocompatibility, and formulating nanofibers and nanocomposites for controlled drug release and wound treatment

Christian Chapa is a leading researcher at the Universidad Autonoma de Ciudad Juarez (Mexico) and head of the NANOMEDICINE research group. His research interests focus on nanomedicine, physico-chemical properties of biomaterials and nanomaterials, mainly with the teragnostic approach. In 2012, he formed the research group for the proposal and execution of research projects related to the preclinical investigation of interactions between biomaterials or nanomaterials with biomolecules, clinical analytes, bioactive compounds, and drugs to develop nanomedicine systems proposed for the identification of molecular targets for the diagnosis and treatment of a range of human diseases. This research group develops activities focused on innovative application of scientific knowledge. In 2020, he formed the Laboratory for Integration of Data and Evidence in Health and Science Reviews LIDERSC to conduct critical reviews with the goal of providing robust and reliable evidence to answer research questions and support decision making in health and science. He was president of the Scientific Committee of the Mexican Society of Biomedical Engineering in 2018-2019 and received recognition from the International Federation for Medical and Biological Engineering for his outstanding work as vice president of the Scientific Committee for the VIII Latin American Congress of Biomedical Engineering. He has more than 30 scientific articles, 8 book chapters and more than 50 presentations in congresses